FDAnews
www.fdanews.com/articles/174386-allurion-technologies-wins-ce-mark-for-elipse-gastric-balloon

Allurion Technologies Wins CE Mark for Elipse Gastric Balloon

December 8, 2015

Wellesley, Mass.-based Allurion Technologies has won CE mark for its Elipse Gastric Balloon for the treatment of obesity.

The swallowable balloon – made of thin, flexible polymer film – fills the stomach and assists patients in feeling full and eating less.

It remains in the stomach for four months, before automatically emptying and being naturally excreted.

The device will initially be available in weight loss centers in France, Italy and the UK, and eventually the Middle East, according to the company. The product is not approved in the U.S. — Michael Cipriano